Skip to main content

and
  1. Article

    Open Access

    Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial

    Potential synergism between Bruton’s tyrosine kinase (BTK) inhibitor and lenalidomide in treating aggressive B-cell lymphoma has been suggested. Here, the authors report a single-arm phase II clinical trial of...

    Changhee Park, Ho Sup Lee, Ka-Won Kang, Won-Sik Lee, Young Rok Do in Nature Communications (2024)

  2. No Access

    Article

    Pan-cancer methylation analysis reveals an inverse correlation of tumor immunogenicity with methylation aberrancy

    Tumor immunogenicity is driven by various genomic and transcriptomic factors but the association with the overall status of methylation aberrancy is not well established. We analyzed The Cancer Genome Atlas pa...

    Changhee Park, Kyeonghun Jeong, Joon-Hyeong Park in Cancer Immunology, Immunotherapy (2021)

  3. Article

    Open Access

    Application of click chemistry in nanoparticle modification and its targeted delivery

    Click chemistry is termed as a group of chemical reactions with favorable reaction rate and orthogonality. Recently, click chemistry is paving the way for novel innovations in biomedical science, and nanoparti...

    Gawon Yi, Jihwan Son, Jihye Yoo, Changhee Park, Heebeom Koo in Biomaterials Research (2018)